Seroyal International, a division of Atrium Innovations recalls
Seroyal International, a division of Atrium Innovations has 1 recall on record with the FDA and USDA, the earliest in 2018 and the latest reported on 15 Aug 2018.
Total recalls1since 2018
Last 12 months0reported
Class I00% of total
Ongoing0latest 15 Aug 2018
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 1 100%Class III 0 0%
Why seroyal international, a division of atrium innovations is recalled
Product types
By year
All seroyal international, a division of atrium innovations recalls, newest first
1 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Food | CLASS II | Genestra AFA-gen capsule 15 mg Niacin/ capsule 300 mg Blue recalledGenestra AFA-gen | Seroyal International, a division of Atrium Innovations | Other | Nationwide |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.